Renishaw plc Annual report and accounts 2012 Chairmans statement Renishaws markets exhibit attractive, long-term structural growth drivers with continuing global investment in production systems and processes.
Sir David R McMurtry Overview Segmental analysis CBE, RDI, FRS, FREng, CEng, FIMechE I am pleased to announce a record Metrology Chairman and Chief Executive set of Group results in terms of both Revenue from our metrology business revenue and profit for the year ended was extremely strong in the last quarter 30th June 2012: a year of further of the year, resulting in revenue for the progress and growth.
full year of 305.8m, compared with 267.0m last year, an increase of 15%.
Total Group revenue for the year was Operating profit was 91.8m, compared 331.9m, 15% ahead of the 288.7m with 87.7m in 2011. for last year.
All geographic areas saw good progress, with growth of 18% in All product lines reported growth, apart the Americas revenue of 76.8m, 14% from encoder products which experienced in the Far East 130.2m, 12% in Europe a slowdown during the year but a recovery 95.7m and 28% in the UK 18.9m in the final quarter.
The machine tool benefitting from a full years trading from andcalibration product lines performed acquisitions.
In the Far East we saw particularly well and there was strong a strong recovery in the final quarter interest for our Equator product which is of the year, principally due to revenue gaining wider exposure and acceptance.
Measurement Devices Limited MDL and Group profit before tax for the year was MTT Investments Limited the latter now 86.0m, compared with 80.4m last year operating as the additive manufacturing excluding a 1.7m exceptional item, product line, acquired last year, also anincrease of 7%.
contributed to the growth in this segment.
In June an additional 17% shareholding Adjusted earnings per share were 95.6p, in MDL was acquired, bringing the an increase of 8% over last years adjusted Companys shareholding to 66%.
Reported earnings per share for the year were 95.6p New product releases during the period 2011 90.8p.
include the RESOLUTE ETR, an absolute encoder with extended temperature range for operation in very cold environments such as aerospace: the XR20-W rotary axis calibrator: the REVO SFP1 surface nish probe and a multi-axis option for our Productivity software.
02 Overview Performance Governance Financial statements Shareholder information Renishaw plc Annual report and accounts 2012 On 3rd February 2012 the Group acquired Thomas Engineering and Construction 2012 performance Limited, an MDL distributor and services provider based in Canada, for the sum 2012 2011 Change of 0.7m, of which 0.2m was paid at the date of acquisition and the balance is Revenue m 331.9 288.7 15% payable over the following two years.
Adjusted operating profit m 83.2 79.3 5% On 26th April 2012 the Group acquired Adjusted profit before taxation m 86.0 80.4 7% R&R Sales LLC R&R for the sum of 2.6m plus additional payments based on Adjusted earnings per share pence 95.6 88.5 8% future performance.
R&R is a US-based supplier of xtures for the measurement Dividend per share pence 38.5 35.0 10% and inspection market.
The acquisition of R&R will provide xturing solutions for our Equator gauge and enable R&R to expand further by utilising Renishaws worldwide Statutory sales and distribution network.
profit before tax m 86.0 82.1 5% Healthcare Revenue from our healthcare business Basic earnings per share pence 95.6 90.8 5% for the year was 26.1m, compared with 21.7m last year, an increase of 20%.
Adjusted gures are stated after excluding the exceptional item, a reversal of an impairment write-down, Spectroscopy sales were at a record in 2011. level, driven by an increasing range of applications in nanotechnology, advanced materials and life sciences, and there was also growth in the dental and neurological product lines.
Revenue m Adjusted profit before tax m During the year, the Board refocused part of the healthcare activities to a smaller 201.2 171.2 181.6 288.7 331.9 41.7 8.8 28.7 80.4 86.0 number of projects, particularly in our neurological products line, and withdrew from the supply of radio frequency coils for use in MRI scanning research which was no longer considered core to our business strategy.
Our spectroscopy product line introduced a new integrated Raman Atomic Force 2008 2009 2010 2011 2012 2008 2009 2010 2011 2012 Microscope package and the neurological product line saw further sales of its neuromate surgical robot used for neurosurgical procedures with the UKs first Stereo Electro Encephalography procedures being carried out to aid the Dividend per share pence Adjusted earnings per treatment of chronic epilepsy at Frenchay share pence Hospital in Bristol.
The next generation of 25.4 7.8 17.6 35.0 38.5 45.9 9.6 32.3 88.5 95.6 neuroinspire surgical planning software achieved CE approval in January 2012.
The continuing significant expenditure on research and development in this segment resulted in an operating loss of 8.6m, compared with a loss of 8.4m for last year.
The Board is targeting that the Healthcare segment will move into 2008 2009 2010 2011 2012 2008 2009 2010 2011 2012 profit in the next two years.
03 Renishaw plc Annual report and accounts 2012 Chairmans statement continued Investment for growth The Group continues to invest for long-term growth and during the year hasinvested 30.3m 2011 16.5m on facilities, plant and machinery and information technology capacity to provide the platform to accommodate growth expectations: In September 2011, the Group completed its purchase of the premises at Miskin, South Wales.
68,500 sq ft of a total of 461,000 sq ft has been refurbished and new CNC machine tools have now been brought intoproduction.
In York, construction of 20,000 sq ft of new premises for occupation by MDL has begun, with completion due at the end of this calendar year.
In Dublin, planning consent has been received for a 26,000 sq ft extension of our manufacturing facility.
This is dueto be completed by the end of thiscalendar year.
At New Mills and Chareld, planning consent has been granted for 230,000sq ft and 50,000 sq ft respectively, primarily to provide Top: Miskin site near Cardiff, SouthWales additional researchand development space onaphased basis.
Middle left: Miskin site before refurbishment started In Slovenia, a new 30,000 sq ft Middle right: Miskin site after facility has been recently completed refurbishment completed and occupied by our associate Above: Wide ranging applications company, RLS.
for MDL products During the year the Group expended Right: R&R xtures holding engine a total of 47.9m 2011 40.0m component for measurement onengineering including research anddevelopment, current product engineering and manufacturing processes, which is planned to increase further in thecoming year.
04 Overview Performance Governance Financial statements Shareholder information Renishaw plc Annual report and accounts 2012 We continue to grow and expand Employees our global marketing and distribution The directors thank the Groups activities to support the new products employees for their continuing support introduced: and significant contribution during this successful year.
The Group has established a new subsidiary company in Mexico to Headcount at the end of June 2012 was market and support the Groups 2,904, an increase of 229 during the year.
products in that country and other There are currently 182 staff vacancies Central American countries.
in the Group, of which 118 are in the UK, We have expanded our working and in common with other UK engineering Above: Renishaw wins National Business Award 2011 premises in Germany, Brazil and companies Renishaw is continuing China, and have refurbished and to experience difficulty in recruiting From left Mike Tobin, CEO, TelecityGroup Winner re-occupied a 16,000 sq ft building 2010, David Maxwell, Partner, Grant Thornton, high-calibre engineers.
BenTaylor, Assistant Chief Executive, Renishaw, in Schaumburg, USA.
andawards host JohnHumphrys, BBC Awards Our Canadian subsidiary has acquired, The Group has again received refurbished and moved into a larger a number of awards during the year, 17,000 sq ft facility in Mississauga, including our 15th Queens Award for Toronto.
Enterprise 2012 in the Innovations Our Spanish subsidiary has relocated Category forthe SP80 ultra-high to newly acquired premises in Barcelona accuracyanalogue scanning probe.
and, in Italy, our subsidiary purchased the property it has occupied for a Outlook number of years.
As expected the final quarter of the year saw an increase in revenue growth Balance sheet and was a record quarter for the Group, and working capital with revenue of 103m.
Renishaws Net cash balances at 30th June 2012 markets exhibit attractive, long-term Above: Award winning SP80 were 21.1m, compared with 23.7m structural growth drivers with continuing in 2011.
In addition, there is an escrow global investment in production systems account amounting to 11.5m and processes.
The Group therefore 30thJune2011 10.8m relating to the continues to invest a significant amount provision of security to the Companys in R&D, manufacturing, marketing and dened benefit pension scheme.
distribution capability with a number of initiatives underway.
Although the world The Group has also nanced an economic outlook is uncertain, the Board increase of 23.1m in working capital, remains optimistic regarding the Groups primarily trade receivables resulting own future and prospects and expects from exceptionally strong revenue in that 2013 will be another year of progress the final quarter.
Directors Dividends David Snowden and Terry Garthwaite A final dividend of 28.2p per share have each completed nine years on the willbepaid on 22nd October 2012 Board and will not be seeking re-election to shareholders on the register on at the AGM on 18th October 2012.
TheBoard is very grateful for their considerable contributions to the Group.
The Board is pleased that Dr David Grant has joined the Board with effect from 25th April 2012 and further appointments will be made in due course.
Resolutions to re-elect all continuing directors will be put to the AGM.
Sir David R McMurtry CBE, RDI, FRS, FREng, CEng, FIMechE Chairman and Chief Executive 25th July 2012 05
